Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OWL vs GSK✓SelectedUSD · GSKOWL vs GSK performance historyLatest closeAs of-2.49%11/19
Stock and ETF performance explorer

OWL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-22.5%
GSK return
+53.5%
Excess return
-76.1%
Maximum drawdown
-67.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%-1.6%-0.9%-2.5%
7D-7.6%-4.7%-2.9%-7.7%
30D+0.2%-4.7%+4.9%0.0%
3M-21.7%-8.8%-13.0%-22.0%
6M-0.4%-4.6%+4.2%-0.5%
YTD-34.4%+1.0%-35.4%-33.8%
1Y-28.9%+6.9%-35.8%-27.9%
All-22.5%+53.5%-76.1%-21.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling